Cytoseek
Bristol, GB · 1 known investors
Hone Bio is a pre-clinical biotech company developing NanoPilot lipid nanoparticle (LNP) targeting technology for extrahepatic drug delivery, engineering LNPs to target specific cell types while blocking off-target liver uptake. It serves therapeutic developers seeking to deliver treatments such as mRNA-based therapies beyond the liver.
Founders & leadership
BC
Ben Carterin
Investors · 1
Frequently asked questions
- What does Cytoseek do?
- Hone Bio is a pre-clinical biotech company developing NanoPilot lipid nanoparticle (LNP) targeting technology for extrahepatic drug delivery, engineering LNPs to target specific cell types while blocking off-target liver uptake. It serves therapeutic developers seeking to deliver treatments such as mRNA-based therapies beyond the liver.
- Who are Cytoseek's investors?
- Cytoseek's investors include Future Planet Capital.
- Where is Cytoseek headquartered?
- Cytoseek is headquartered in Bristol, GB.